GlassScriptPhysician profile
Keith Lynn Davis
NPI 1952488215
$742.41
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.49 · 2020: $29.46 · 2022: $258 · 2023: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.52 | 2022-2023 | Vraylar, Mavyret |
| Janssen Pharmaceuticals, INC | $86.20 | 2022-2023 | Spravato |
| Lilly USA, LLC | $75.19 | 2022-2023 | Jardiance, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $58.95 | 2022-2023 | Rexulti |
| Indivior INC. | $50.77 | 2022-2023 | Sublocade |
| Bayer Healthcare Pharmaceuticals INC. | $44.24 | 2023 | |
| Alkermes, INC. | $43.23 | 2020-2023 | Vivitrol |
| Amgen INC. | $36.73 | 2022 | |
| Novo Nordisk INC | $33.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.37 | 2022-2023 | Breztri |
| Merck Sharp & Dohme LLC | $32.28 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.55 | 2022 | |
| Exact Sciences Corporation | $16.99 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $14.58 | 2019 | |
| Exeltis, USA INC. | $14.26 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.84 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.